We are live on ! Find out more
SWAGW icon

Stran & Company Warrant

4 hedge funds and large institutions have $29.8K invested in Stran & Company Warrant in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1.21% less ownership

Funds ownership: 5.24%4.03% (-1.2%)

20% less funds holding

Funds holding: 54 (-1)

35% less capital invested

Capital invested by funds: $46.1K → $29.8K (-$16.3K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$7
Name Holding Trade Value Shares
Change
Change in
Stake
AC
1
Armistice Capital
New York
$21.8K
WAM
2
Warberg Asset Management
Illinois
$7.27K
CS
3
Clear Street
New York
$662
UBS Group
4
UBS Group
Switzerland
$113 -$7 -145 -5%

SWAGW Hedge Fund Activity: Q4 2023 in Review

4 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Stran & Company Warrant (SWAGW) for Q4 2023, worth a combined $29.8K — down 35% from $46.1K a quarter earlier.

Fund positioning in SWAGW was balanced in Q4 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was UBS Group, cutting an estimated $7.

  • 4 institutional investors held Stran & Company Warrant (SWAGW) as of Q4 2023, down from 5 in Q3 2023.
  • Funds reported $29.8K of Stran & Company Warrant stock for Q4 2023, down 35% quarter-over-quarter.
  • 0 funds opened new Stran & Company Warrant positions in Q4 2023 and 0 closed out.
  • The largest Stran & Company Warrant seller in Q4 2023 was UBS Group, an estimated $7 sold.

Based on aggregated 13F filings for Q4 2023.